Somewhere around 200 million people worldwide live with age-related macular degeneration, and for those with the dry form of ...
An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help ...
Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease‑agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
A new laser-based treatment could help the eye repair itself before vision loss becomes permanent.
ALPHARETTA, Ga., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...
Eye care should not begin only when vision becomes blurry. The eyes change through childhood, school years, adulthood, and older age, and each stage brings different risks. Children need healthy ...
LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book ...
Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...
Caption: Testing for macular degeneration is simple, but treatment for the common eye disease that can cause blindness isn't so straightforward. A new Onta ...